P. Bentley

3.1k total citations
75 papers, 2.4k citations indexed

About

P. Bentley is a scholar working on Molecular Biology, Pharmacology and Biochemistry. According to data from OpenAlex, P. Bentley has authored 75 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 28 papers in Pharmacology and 24 papers in Biochemistry. Recurrent topics in P. Bentley's work include Pharmacogenetics and Drug Metabolism (24 papers), Eicosanoids and Hypertension Pharmacology (21 papers) and Peroxisome Proliferator-Activated Receptors (12 papers). P. Bentley is often cited by papers focused on Pharmacogenetics and Drug Metabolism (24 papers), Eicosanoids and Hypertension Pharmacology (21 papers) and Peroxisome Proliferator-Activated Receptors (12 papers). P. Bentley collaborates with scholars based in Switzerland, Germany and United Kingdom. P. Bentley's co-authors include Franz Oesch, W. Stäubli, F. Bieri, Hansruedi Glatt, Felix Waechter, Karl L. Platt, F. Waechter, Samar F. Muakkassah-Kelly, P. Grasso and I. C. Calder and has published in prestigious journals such as Nature, Science and Journal of Biological Chemistry.

In The Last Decade

P. Bentley

75 papers receiving 2.2k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
P. Bentley 1.1k 838 615 454 279 75 2.4k
Thomas M. Guenthner 938 0.8× 1.0k 1.2× 567 0.9× 557 1.2× 355 1.3× 70 2.5k
Jaime Kapitulnik 1.1k 1.0× 500 0.6× 167 0.3× 419 0.9× 222 0.8× 71 2.1k
James J. Kocsis 723 0.6× 523 0.6× 440 0.7× 728 1.6× 188 0.7× 48 2.8k
Charles V. Smith 1.0k 0.9× 364 0.4× 394 0.6× 224 0.5× 304 1.1× 63 2.6k
Michael J. Fasco 1.3k 1.1× 1.5k 1.7× 369 0.6× 549 1.2× 709 2.5× 69 3.9k
Jacques Gielen 1.7k 1.5× 1.2k 1.5× 395 0.6× 985 2.2× 864 3.1× 100 3.8k
Elena Chiarpotto 1.5k 1.3× 307 0.4× 256 0.4× 318 0.7× 197 0.7× 75 3.5k
Richard T. Okita 586 0.5× 576 0.7× 435 0.7× 150 0.3× 213 0.8× 51 1.5k
Linda M. Reik 845 0.7× 1.5k 1.8× 301 0.5× 445 1.0× 614 2.2× 28 2.6k
Alvah H. Phillips 899 0.8× 819 1.0× 313 0.5× 114 0.3× 334 1.2× 16 1.9k

Countries citing papers authored by P. Bentley

Since Specialization
Citations

This map shows the geographic impact of P. Bentley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Bentley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Bentley more than expected).

Fields of papers citing papers by P. Bentley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Bentley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Bentley. The network helps show where P. Bentley may publish in the future.

Co-authorship network of co-authors of P. Bentley

This figure shows the co-authorship network connecting the top 25 collaborators of P. Bentley. A scholar is included among the top collaborators of P. Bentley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Bentley. P. Bentley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moggs, Jonathan G., Timothy K. MacLachlan, Hans‐Joerg Martus, & P. Bentley. (2016). Derisking Drug-Induced Carcinogenicity for Novel Therapeutics. Trends in cancer. 2(8). 398–408. 9 indexed citations
2.
Vickers, Alison E.M., P. Bentley, & Robyn L. Fisher. (2006). Consequences of mitochondrial injury induced by pharmaceutical fatty acid oxidation inhibitors is characterized in human and rat liver slices. Toxicology in Vitro. 20(7). 1173–1182. 42 indexed citations
3.
Bentley, P., et al.. (2000). The Industry View on Long‐Term Toxicology Testing in Drug Development of Human Pharmaceuticals. Pharmacology & Toxicology. 86(s1). 1–5. 9 indexed citations
4.
Kahl, Steven D., Peter S. McPherson, T. Lewis, et al.. (1994). Radioimmunoassay for the Calcium Release Channel Agonist Ryanodine. Analytical Biochemistry. 218(1). 55–62. 5 indexed citations
5.
Bentley, P., et al.. (1993). Hepatic peroxisome proliferation in rodents and its significance for humans. Food and Chemical Toxicology. 31(11). 857–907. 235 indexed citations
6.
Lowe, K. C. & P. Bentley. (1992). Retention of Perfluorochemicals in Rat Liver and Spleen. Biomaterials Artificial Cells and Immobilization Biotechnology. 20(2-4). 1029–1031. 6 indexed citations
7.
Bentley, P., et al.. (1992). Lymphoid Tissue Responses to Concentrated Perfluorochemical Emulsions in Rats. Biomaterials Artificial Cells and Immobilization Biotechnology. 20(2-4). 1033–1036. 3 indexed citations
8.
Bieri, F., W. Stäubli, Samar F. Muakkassah-Kelly, et al.. (1991). Studies on the mechanism of induction of microsomal cytochrome P452 and peroxisomal bifunctional enzyme mRNAs by nafenopin in primary cultures of adult rat hepatocytes. Biochemical Pharmacology. 41(2). 310–312. 8 indexed citations
9.
Bentley, P., F. Bieri, Samar F. Muakkassah-Kelly, et al.. (1990). Increase in Hepatocyte and Nuclear Volume and Decrease in the Population of Binucleated Cells in Preneoplastic Foci of Rat Liver: A Stereological Study Using the Nucleator Method. Hepatology. 11(2). 286–297. 53 indexed citations
10.
Sagelsdorff, Peter, P. Dollenmeier, Daniel Ebner, et al.. (1990). Lack of covalent binding to DNA of di-n-octyltin dichloride (DOTC) in vivo and in vitro. Toxicology Letters. 50(2-3). 179–188. 7 indexed citations
11.
Berenbaum, M. C., et al.. (1990). Perfluorochemicals and Photodynamic Therapy in Mice. Advances in experimental medicine and biology. 277. 277–282. 7 indexed citations
12.
Bieri, F., Samar F. Muakkassah-Kelly, F. Waechter, et al.. (1990). The significance of in vitro studies on peroxisome proliferation. Toxicology in Vitro. 4(4-5). 428–431. 9 indexed citations
15.
Bronfman, Miguel, Ariel Orellana, F. Bieri, et al.. (1989). Potentiation of diacylglycerol-activated protein kinase C by acyl-coenzyme a thioesters of hypolipidaemic drugs. Biochemical and Biophysical Research Communications. 159(3). 1026–1031. 60 indexed citations
16.
Bieri, F., M R Nemali, Samar F. Muakkassah-Kelly, et al.. (1988). Increased peroxisomal enzyme mRNA levels in adult rat hepatocytes cultured in a chemically defined medium and treated with nafenopin. Toxicology in Vitro. 2(4). 235–240. 11 indexed citations
17.
Bieri, F., W. Stäubli, F. Waechter, Samar F. Muakkassah-Kelly, & P. Bentley. (1988). Stimulation of DNA synthesis but not of peroxisomal ?-oxidation by nafenopin in primary cultures of marmoset hepatocytes. Cell Biology International Reports. 12(12). 1077–1087. 19 indexed citations
18.
Waechter, Felix, et al.. (1988). Organ distribution of epoxide hydrolases in cytosolic and microsomal fractions of normal and nafenopin-treated male DBA/2 mice. Biochemical Pharmacology. 37(20). 3897–3903. 16 indexed citations
19.
Muakkassah-Kelly, Samar F., David A. Jans, Nicholas Lydon, et al.. (1988). Electroporation of Cultured adult rat hepatocytes with the c-myc gene potentiates DNA synthesis in response to epidermal growth factor. Experimental Cell Research. 178(2). 296–306. 11 indexed citations
20.
Muakkassah-Kelly, Samar F., F. Bieri, F. Waechter, P. Bentley, & W. Stäubli. (1988). The use of primary cultures of adult rat hepatocytes to study induction of enzymes and DNA synthesis: Effect of nafenopin and electroporation. Cellular and Molecular Life Sciences. 44(10). 823–827. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026